476 related articles for article (PubMed ID: 23845423)
1. Crystal structure of the Plasmodium falciparum thioredoxin reductase-thioredoxin complex.
Fritz-Wolf K; Jortzik E; Stumpf M; Preuss J; Iozef R; Rahlfs S; Becker K
J Mol Biol; 2013 Sep; 425(18):3446-60. PubMed ID: 23845423
[TBL] [Abstract][Full Text] [Related]
2. Thioredoxin reductase from Plasmodium falciparum: evidence for interaction between the C-terminal cysteine residues and the active site disulfide-dithiol.
Wang PF; Arscott LD; Gilberger TW; Müller S; Williams CH
Biochemistry; 1999 Mar; 38(10):3187-96. PubMed ID: 10074374
[TBL] [Abstract][Full Text] [Related]
3. The malaria parasite Plasmodium falciparum possesses a functional thioredoxin system.
Krnajski Z; Gilberger TW; Walter RD; Müller S
Mol Biochem Parasitol; 2001 Feb; 112(2):219-28. PubMed ID: 11223129
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of Plasmodium falciparum thioredoxin reductase, a validated drug target.
Boumis G; Giardina G; Angelucci F; Bellelli A; Brunori M; Dimastrogiovanni D; Saccoccia F; Miele AE
Biochem Biophys Res Commun; 2012 Sep; 425(4):806-11. PubMed ID: 22889878
[TBL] [Abstract][Full Text] [Related]
5. Plasmodium falciparum Thioredoxin Reductase (PfTrxR) and Its Role as a Target for New Antimalarial Discovery.
McCarty SE; Schellenberger A; Goodwin DC; Fuanta NR; Tekwani BL; Calderón AI
Molecules; 2015 Jun; 20(6):11459-73. PubMed ID: 26111176
[TBL] [Abstract][Full Text] [Related]
6. Specific inhibitors of Plasmodium falciparum thioredoxin reductase as potential antimalarial agents.
Andricopulo AD; Akoachere MB; Krogh R; Nickel C; McLeish MJ; Kenyon GL; Arscott LD; Williams CH; Davioud-Charvet E; Becker K
Bioorg Med Chem Lett; 2006 Apr; 16(8):2283-92. PubMed ID: 16458512
[TBL] [Abstract][Full Text] [Related]
7. Mechanism-based inactivation of thioredoxin reductase from Plasmodium falciparum by Mannich bases. Implication for cytotoxicity.
Davioud-Charvet E; McLeish MJ; Veine DM; Giegel D; Arscott LD; Andricopulo AD; Becker K; Müller S; Schirmer RH; Williams CH; Kenyon GL
Biochemistry; 2003 Nov; 42(45):13319-30. PubMed ID: 14609342
[TBL] [Abstract][Full Text] [Related]
8. The structure of human thioredoxin reductase 1 provides insights into C-terminal rearrangements during catalysis.
Fritz-Wolf K; Urig S; Becker K
J Mol Biol; 2007 Jun; 370(1):116-27. PubMed ID: 17512005
[TBL] [Abstract][Full Text] [Related]
9. Discovery and biochemical characterization of Plasmodium thioredoxin reductase inhibitors from an antimalarial set.
Theobald AJ; Caballero I; Coma I; Colmenarejo G; Cid C; Gamo FJ; Hibbs MJ; Bass AL; Thomas DA
Biochemistry; 2012 Jun; 51(23):4764-71. PubMed ID: 22612231
[TBL] [Abstract][Full Text] [Related]
10. Structural model of the Plasmodium falciparum thioredoxin reductase:a novel target for antimalarial drugs.
Banerjee AK; Arora N; Murty US
J Vector Borne Dis; 2009 Sep; 46(3):171-83. PubMed ID: 19724080
[TBL] [Abstract][Full Text] [Related]
11. Protein-protein interactions at an enzyme-substrate interface: characterization of transient reaction intermediates throughout a full catalytic cycle of Escherichia coli thioredoxin reductase.
Negri A; Rodríguez-Larrea D; Marco E; Jiménez-Ruiz A; Sánchez-Ruiz JM; Gago F
Proteins; 2010 Jan; 78(1):36-51. PubMed ID: 19585660
[TBL] [Abstract][Full Text] [Related]
12. Thioredoxin and glutathione systems in Plasmodium falciparum.
Jortzik E; Becker K
Int J Med Microbiol; 2012 Oct; 302(4-5):187-94. PubMed ID: 22939033
[TBL] [Abstract][Full Text] [Related]
13. Double-drug development against antioxidant enzymes from Plasmodium falciparum.
Biot C; Dessolin J; Grellier P; Davioud-Charvet E
Redox Rep; 2003; 8(5):280-3. PubMed ID: 14962365
[TBL] [Abstract][Full Text] [Related]
14. Thioredoxin system from Deinococcus radiodurans.
Obiero J; Pittet V; Bonderoff SA; Sanders DA
J Bacteriol; 2010 Jan; 192(2):494-501. PubMed ID: 19933368
[TBL] [Abstract][Full Text] [Related]
15. Thioredoxin networks in the malarial parasite Plasmodium falciparum.
Nickel C; Rahlfs S; Deponte M; Koncarevic S; Becker K
Antioxid Redox Signal; 2006; 8(7-8):1227-39. PubMed ID: 16910770
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of Escherichia coli thioredoxin reductase refined at 2 A resolution. Implications for a large conformational change during catalysis.
Waksman G; Krishna TS; Williams CH; Kuriyan J
J Mol Biol; 1994 Feb; 236(3):800-16. PubMed ID: 8114095
[TBL] [Abstract][Full Text] [Related]
17. Molecular bases of thioredoxin and thioredoxin reductase-mediated prooxidant actions of (-)-epigallocatechin-3-gallate.
Zhang H; Cao D; Cui W; Ji M; Qian X; Zhong L
Free Radic Biol Med; 2010 Dec; 49(12):2010-8. PubMed ID: 20951799
[TBL] [Abstract][Full Text] [Related]
18. Redox regulation of Plasmodium falciparum ornithine δ-aminotransferase.
Jortzik E; Fritz-Wolf K; Sturm N; Hipp M; Rahlfs S; Becker K
J Mol Biol; 2010 Sep; 402(2):445-59. PubMed ID: 20673832
[TBL] [Abstract][Full Text] [Related]
19. A mechanistic investigation of the C-terminal redox motif of thioredoxin reductase from Plasmodium falciparum.
Snider GW; Dustin CM; Ruggles EL; Hondal RJ
Biochemistry; 2014 Jan; 53(3):601-9. PubMed ID: 24400600
[TBL] [Abstract][Full Text] [Related]
20. Thioredoxin reductase-thioredoxin fusion enzyme from Mycobacterium leprae: comparison with the separately expressed thioredoxin reductase.
Wang PF; Marcinkeviciene J; Williams CH; Blanchard JS
Biochemistry; 1998 Nov; 37(46):16378-89. PubMed ID: 9819230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
